TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Invion ( (AU:IVX) ) has shared an announcement.
Invion Limited has successfully raised approximately $0.8 million through the issuance of Convertible Notes, primarily backed by Summit Biotech Fund and a specialist microcap fund. The capital raised will be used to settle outstanding obligations with Lind Global Fund II LP and for general working capital. This financial maneuver positions Invion to pursue significant growth opportunities, including securing global licensing agreements for its Photosoft technology platform, which could enhance its industry positioning and stakeholder value.
More about Invion
Invion Limited operates in the biotechnology industry, focusing on developing and commercializing its Photosoft technology platform for therapeutics and diagnostics. The company aims to secure global licensing agreements to expand its market reach.
Average Trading Volume: 112,655
Technical Sentiment Signal: Sell
Current Market Cap: A$8.56M
See more insights into IVX stock on TipRanks’ Stock Analysis page.